ShadowBuys
Sign inJoin for free

BridgeBio Pharma (BBIO)

Healthcare · Biotechnology

1 member of Congress has disclosed 8 trades in BridgeBio Pharma (BBIO) since 2025: 7 buys and 1 sale. The most recent was disclosed on Oct 12, 2026.

Trades disclosed
8
Members trading
1
Buys / sells
7 / 1
Reported value
$8K–$120K

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow BBIO

What else is happening at BBIO

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. BBIOFinancial report·SEC EDGAR

    BBIO: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Oct 29, 2026, 4:52 PM EDTEvent / period: Sep 30, 2026Original source ↗
  2. BBIOCompany announcement·SEC EDGAR

    BBIO: Financial results

    Filed 8-K for an event or period dated 2026-10-29. Financial results.

    Public: Oct 29, 2026, 4:03 PM EDTEvent / period: Oct 29, 2026Original source ↗
  3. BBIOCompany announcement·SEC EDGAR

    BBIO: Other company developments

    Filed 8-K for an event or period dated 2026-10-06. Other company developments.

    Public: Oct 13, 2026, 6:01 AM EDTEvent / period: Oct 6, 2026Original source ↗

Who traded BBIO

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.